Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Damjan Manevski

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
The Journal of Biological Chemistry|May 9, 2025
Extent of N-glycosylation of the metalloproteinase inhibitor and cytokine TIMP-1 determines pancreatic cancer cell proliferation and survival via CD63Daniel Häußler, Damjan Manevski, Julian Frädrich, et al.
Cell Reports. Medicine|January 21, 2026
Multimodal profiling of pancreatic cancer reveals a TIMP-1-dominated secretory profile determining pro-tumor immunoinstruction in human cancersJulian Frädrich, Carmen Mota Reyes, Michel Hendel, et al.
European Journal of Cancer (Oxford, England : 1990)|February 11, 2023
Population mortality in advanced melanoma patients with and without response and progression; data from the Dutch Melanoma Treatment RegistryJesper van Breeschoten, Alfons J M van den Eertwegh, Doranne L Hilarius, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
The Journal of Biological Chemistry|May 9, 2025
Extent of N-glycosylation of the metalloproteinase inhibitor and cytokine TIMP-1 determines pancreatic cancer cell proliferation and survival via CD63Daniel Häußler, Damjan Manevski, Julian Frädrich, et al.
Cell Reports. Medicine|January 21, 2026
Multimodal profiling of pancreatic cancer reveals a TIMP-1-dominated secretory profile determining pro-tumor immunoinstruction in human cancersJulian Frädrich, Carmen Mota Reyes, Michel Hendel, et al.
European Journal of Cancer (Oxford, England : 1990)|February 11, 2023
Population mortality in advanced melanoma patients with and without response and progression; data from the Dutch Melanoma Treatment RegistryJesper van Breeschoten, Alfons J M van den Eertwegh, Doranne L Hilarius, et al.
Pageof 2